About Breakthrough Symposium
The first-ever Breakthrough Symposium was held in 2018 to bring together individuals and organizations that lead the biotechnology community. Participants shared the latest advancements in gene and cell therapy, gene editing and more, while networking with thought leaders who will spark tomorrow’s breakthroughs and celebrate the latest developments in bioscience.
Breakthrough Symposium is hosted by Aldevron in its corporate home of Fargo, North Dakota. Aldevron is a leading supplier of plasmid DNA, proteins, enzymes, antibodies, and other biologicals that enable groundbreaking achievement in life science.
Here are a few of the topics from our accomplished roster of speakers who took part at the inaugural event:
Learn about the novel developments in gene therapy to treat cancer
from Laurence Cooper, CEO of Ziopharm Oncology and David Courtman, CSO of Northern Therapeutics.
Discover the potential for gene editing and CRISPR/Cas9
from Matthew Porteus, Associate Professor, Department of Pediatrics, the Institute of Stem Cell Biology and Regenerative Medicine at Stanford University and Kris Saha, Department of Biomedical Engineering, University of Wisconsin-Madison
Collaborate on the latest gene therapy manufacturing developments
with Andrew Moreo, Operations Manager, GMP and Viral Vector Core Facilities, Nationwide Children’s Hospital and Anne Kantardjieff, Director of Plasmids and Small Molecules Manufacturing, bluebird bio
Hear about the progress in AAV gene therapy
from Luk H. Vandenberghe, Assistant Professor at Harvard Medical School and Mark Osborn, Assistant Professor, University of Minnesota
Be inspired by the story of Emily Whitehead
presented by Tom Whitehead, Emily’s father and the co-founder of the Emily Whitehead Foundation.
See the latest in biological manufacturing facilities
by touring the recently opened 70,000 square-foot Aldevron building, the largest plasmid DNA facility in the world.